Current Gene Therapy

Papers
(The H4-Index of Current Gene Therapy is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Effective Combination of Single-cell Analysis and Gene Therapy51
Gene Augmentation Techniques to Stimulate Wound Healing Process: Progress and Prospects38
Next-Generation Whole-Exome Pattern: Advanced Methods and Clinical Significance37
Evaluation of the Cellular Effects of miR-30d-3p in A549 Cells Under Normoxic and Hypoxic Conditions33
Identifying Key Epigenetic Modification-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma and Cellular Validation32
Synergizing CRISPR-Cas9 with Advanced Artificial Intelligence and Machine Learning for Precision Drug Delivery: Technological Nexus and Regulatory Insights30
A Comprehensive Review of Genetic Risk Factors for Alzheimer’s Disease Development26
A Retrospective Analysis of the Lauren Classification in the Choice of XELOX or SOX as an Adjuvant Chemotherapy for Gastric Cancer26
Identifying ARRB2 as a Prognostic Biomarker and Key Player in the Tumor Microenvironment of Pancreatic Cancer through scPagwas Methodology25
Acknowledgements to Reviewers23
DNA Vaccines to Improve Immunogenicity and Effectiveness in Cancer Vaccinations: Advancement and Developments22
Advancing siRNA Therapeutics with Pharmacometrics: A Review of Modeling Approaches and Clinical Applications22
Applications of L-Arginine in Pregnancy and Beyond: An Emerging Pharmacogenomic Approach22
MARVELD3 as a Prognostic Biomarker in Esophageal Cancer and its Relationship with m6A Modification, Cuproptosis, and the ceRNA Regulatory Network22
Therapeutic Potential of POU3F3, a Novel Long Non-coding RNA, Alleviates the Pathogenesis of Osteoarthritis by Regulating the miR-29a- 3p/FOXO3 Axis21
MDAlmc: A Novel Low-rank Matrix Completion Model for MiRNADisease Association Prediction by Integrating Similarities among MiRNAs and Diseases21
Comprehensive Analysis and Experimental Validation of HEPACAM2 as a Potential Prognosis Biomarker and Immunotherapy Target in Colorectal Cancer19
Identification and Validation of Amino Acid Metabolism-Related Biomarkers and Investigation of their Potential Mechanisms in Lung Adenocarcinoma18
TRPM8 as a Potential Biomarker and Therapeutic Target for Gastric Cancer Identified by a Combination of Text Mining and RNA Sequencing18
Human Virus-Like Proteins: Implications for Gene Therapy18
0.11987805366516